SUBSCRIBE
Biohealth Innovation
Founding Member of
SUBSCRIBE
Events Calendar
Gene Therapy Product Activity & Comparability & the Evaluation of T-Cells
Identification & Standardization of Methods for Assessing Gene Therapy Product Activity & Comparability & the Evaluation of T-Cell Therapies
Workshop for the Identification and Standardization of Methods for Assessing Gene Therapy Product Activity and Comparability and the Evaluation of T-Cell Therapies
The Standards Coordinating Body (SCB) for Regenerative Medicine, the U.S. Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST) are holding a workshop, co-organized by the United States Pharmacopeia (USP), on November 16 and 17. The workshop will be held at the USP headquarters in Rockville, MD.
The regenerative medicine field is expanding rapidly, and T-cell therapies and gene therapy products are at the forefront of that growth. However, at this time there is little standardization across manufacturers of these products. In this workshop, we will discuss the current global status of the fields of gene therapy, gene modification, and T-cell therapy with a specific emphasis on current standardization and collaborative efforts, and the current challenges and gaps.
Although gene therapy standards will be the focus of this workshop, the discussions will also touch on challenges relevant to cell therapy standards.
We look forward to working together to inform better standard practices to advance the implementation of advanced therapy products.
Mid-Atlantic Healthcare Real Estate Summit
Exploring the region's market challenges, investment opportunities, development pipeline, innovative trends and more
WHAT YOU'LL LEARN AT THIS COMMERCIAL REAL ESTATE HEALTHCARE CONFERENCE
- What is continuing to drive the investment appetite for the healthcare sector within the Mid-Atlantic region?
- Between construction costs and rising interest rates, how has the impact of the last few months affected current projects? Are there certain strategies put in place to keep costs down?
- With an increase in investment and occupancy, who is currently putting money into healthcare facilities or medical office buildings in the DC area and beyond? What types of deals are moving forward? What are investors and brokers seeing in terms of leasing activity?
- What types of medical facilities or offices are seeing the most attraction in this market? Are there certain areas where investors are actively seeking?
- How has the market expanded to accommodate the behavioral health real estate demand? What are the challenges or opportunities that have come from this?
- What are current tenant demands? What types of innovations, designs and amenities are being implemented in facilities?
- What are some of the emerging technologies that might revolutionize our notions about health and wellness as well as the patient experience? Do we expect AI to play a huge part in future medical technology?
How You'll Do More Business: With current projects like Trammel Crow's The Wellness Center at West Falls and UMD Medical System's 60,000-square-foot medical building in Laurel, Md, the Mid-Atlantic region is seeing a strong healthcare development pipeline. Despite some arising industry challenges happening in the past few years, the DC metro area's medical office market ended 2022 with 400,000 sqf of net occupancy gains and a low vacancy of 10.9%. Join us in Washington D.C. to hear from leading healthcare professionals as they discuss the region's development pipeline, investment strategies, leasing activity, property types, new opportunities and more!
Who You'll Meet: Developers, owners, investors, construction, designers, architects, financial professionals and more!
News, Projects, and Activity:
- REIT Welltower Pays $78M To Acquire K Street Medical Office
- Somatus Expands Partnership with Inova to Further Enhance Care and Improve Outcomes for Patients
- Trammell Crow Company’s 124,000-square-foot The Wellness Center at West Falls in Merrifield, VA
- Inova Fairfax named top hospital in region, state by U.S. News
- A look back on the 2022 CRE themes in the healthcare industry in the D.C. metro area
- LifeBridge Health opens new center focused on primary care for LGBTQIA+ community
For questions, recommendations, comments, press inquiries, or if you are interested in sponsoring, please email our Mid-Atlantic Event Producer, Katie Telder, at katie.telderbisnow.com. To request disability-related accommodations, please contact lizzie.smith@bisnow.com no later than seven business days prior to the event.
Noble Life Sciences Inc: Navigating Cell Therapy Product Development: From Concept to IND Enabling
Join us on November 16th for an insightful webinar, "Navigating Cell Therapy Product Development: From Proof of Concept to IND Enabling Studies," featuring the expertise of Stephen Horrigan. In this comprehensive webinar, you will gain invaluable insights into the intricate world of cell therapy product development, from the initial proof of concept to the crucial IND enabling studies.
Defense TechConnect 2023
Meet-and-greet with the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) agencies! They're the nation's largest source of early stage, high-risk research and development funding for small businesses that provide more than $4 billion annually in competitive awards, enabling entrepreneurs to develop new technologies and ultimately facilitate the commercialization of innovation.
Register for Defense TechConnect 2023 and get the opportunity to meet with and hear from SBIR/STTR leaders and experts, as they share their insights on how to submit more competitive proposals and leverage available resources.
SBIR/STTR Fall Innovation Conference
Seeding America's Future Innovations
Connect directly with over $4 billion in early stage funding. Learn how to compete for funding, while networking with global industry scouts, investors, and key federal leadership representing the nation's largest seed fund.
SBIR/STTR INNOVATION SUMMIT
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are the nation's largest source of early stage, high risk research and development funding for small businesses. These programs provide more than $4 billion annually in competitive awards, enabling entrepreneurs to develop new technologies and ultimately facilitate the commercialization of innovation. Attendees will have the opportunity to meet with and hear from SBIR/STTR leaders and experts, as they learn how to submit more competitive proposals and leverage available resources.
JHTV - Open House: Funding Translational Research
Join fellow researchers for an informational presentation by JHTV staff, followed by a casual networking reception. The session will provide Johns Hopkins researchers with an overview of basic concepts in university commercialization and sources (and tips!) for funding your project. It is recommended for faculty, postdocs, and graduate students who are solving scientific problems in the lab that can improve the world.
Special guest, Executive Director of MSCRF, Ruchika Nijhara, Ph.D.
Discussion Topics:
- What is commercialization and why should I pursue it?
- How do I secure funding through JHU translational grants and what other funding opportunities exist?
- What support does the university provide for me in terms of funding, business advice and connections to investors/industry partners?
- What is the Maryland Stem Cell Research Fund (MSCRF) and who is eligible to apply for the grants?
- What is the range of funding available from MSCRF?
- What is the process for applying for MSCRF funding?
Post-discussion we encourage you to stay for a reception to meet the JHTV team and network with fellow inventors. Beer and snacks will be served.
Event Details:
- December 5 | East Baltimore | FastForward, 1812 Ashland Ave. | 5-6:30 pm
https://ventures.jhu.edu/event/open-house-funding-translational-research-dec-2023/
TEDCO's SBIR/STTR Proposal Lab Open Forum
NCI Technology Opportunity Webinar: Nestorone/ Testosterone Male Contraceptive Gel
Register to attend a free NIH webinar. Attendees will learn about a first-of-its-kind male contraceptive hormonal gel, Nestorone/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of ending application. This presentation will showcase NES/T gel as an innovative, user-controlled option for male contraception.
EIR Feedback Day - December 13
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
EIR Feedback Day, January 17
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!